Our Pricing

Saxenda Injection: Complete UK Guide to Liraglutide Weight Loss Treatment

Saxenda injection is a once-daily injectable weight loss treatment containing liraglutide 6mg/ml, licensed by the MHRA for adults with a BMI of 30 or above, or 27 with weight-related health conditions. Approved following the SCALE clinical trial programme, this GLP-1 receptor agonist has helped thousands of UK patients achieve clinically significant weight loss when combined with a reduced-calorie diet and increased physical activity. All Saxenda prescriptions at Cured Pharmacy require assessment by our UK-registered clinical team to ensure suitability and safety.

How Does Saxenda Injection Work for Weight Loss?

Saxenda injection works by mimicking the action of GLP-1 (glucagon-like peptide-1), a naturally occurring hormone that regulates appetite and food intake. When administered subcutaneously once daily, liraglutide binds to GLP-1 receptors in the brain's appetite centres, reducing hunger signals and increasing feelings of fullness after meals [1]. This dual mechanism helps patients consume fewer calories naturally, without the constant battle against overwhelming hunger that often derails traditional diet-only approaches.

Clinical evidence from the SCALE Obesity and Prediabetes trial demonstrated that adults using Saxenda injection alongside lifestyle modifications lost an average of 8% of their initial body weight over 56 weeks, compared to 2.6% in the placebo group [1]. Approximately 63% of patients achieved at least 5% weight loss—the threshold considered clinically meaningful for reducing obesity-related health risks including type 2 diabetes, hypertension, and sleep apnoea. The medication also slows gastric emptying, which prolongs satiety after eating and helps stabilise blood glucose levels throughout the day [2].

At Cured Pharmacy, our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees every Saxenda prescription to ensure patients receive appropriate dosing guidance and ongoing support. The treatment requires gradual dose escalation over five weeks to minimise gastrointestinal side effects, starting at 0.6mg daily and increasing weekly to the maintenance dose of 3mg daily. This titration schedule is critical for tolerability and long-term adherence, which directly correlates with weight loss success in real-world use.

Saxenda Injection Dosage and Administration Guide

Proper storage of your Saxenda injection pens is essential for maintaining medication stability and effectiveness. Unopened pens must be refrigerated at 2-8°C and protected from light until first use. Once in use, the pen may be stored at room temperature below 30°C or continued in the refrigerator for up to 30 days, after which it must be discarded even if medication remains [3]. Never freeze Saxenda pens, and always remove the needle immediately after each injection to prevent contamination and maintain accurate dosing.

Missing occasional doses happens, but consistent adherence maximises weight loss results seen in clinical trials. If you miss a Saxenda injection and fewer than 12 hours have passed since your usual time, administer the dose immediately. If more than 12 hours have elapsed, skip that dose entirely and resume your normal schedule the following day—never double up to compensate for missed doses, as this significantly increases the risk of severe nausea and vomiting [2]. Setting daily phone reminders or pairing injections with an existing routine like morning coffee helps most patients maintain consistency.

Step-by-Step Injection Technique

Saxenda injection should be administered once daily at any time, with or without food, though consistency in timing helps establish routine adherence. The pre-filled pen is designed for subcutaneous injection into the abdomen, thigh, or upper arm, rotating injection sites within the same body region to prevent lipodystrophy [3]. Each pen contains 18mg of liraglutide across 30 doses at the maximum 3mg strength, or more doses during the titration phase when using lower daily amounts.

The five-week dose escalation schedule begins at 0.6mg daily for week one, increasing by 0.6mg increments each week: 1.2mg in week two, 1.8mg in week three, 2.4mg in week four, reaching the full 3mg maintenance dose in week five. Patients who experience persistent nausea or vomiting may delay dose increases by one additional week under prescriber guidance, though moving too slowly can reduce overall efficacy. Our clinical team provides detailed injection training resources and ongoing support throughout your Saxenda journey to optimise both technique and outcomes.

Saxenda Injection Side Effects and Safety Profile

The most common side effects associated with Saxenda injection are gastrointestinal in nature, affecting more than 10% of users in clinical trials. Nausea is the predominant complaint, particularly during dose escalation, alongside diarrhoea, constipation, vomiting, and dyspepsia [1]. These symptoms typically diminish within days to weeks as the body adapts to liraglutide, and the gradual titration schedule specifically aims to minimise their severity. Eating smaller, more frequent meals and avoiding high-fat foods can further reduce gastrointestinal discomfort during the initial treatment period.

Serious but rare adverse events require immediate medical attention and include symptoms of pancreatitis (severe persistent abdominal pain radiating to the back), gallbladder problems (upper right abdominal pain, fever, jaundice), and signs of thyroid tumours (neck lump, persistent hoarseness, difficulty swallowing) [2]. Saxenda injection carries a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though causality in humans has not been established. The medication is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Hypoglycaemia is uncommon in patients without diabetes using Saxenda injection alone, but risk increases when combined with insulin or sulfonylureas. Our prescribers carefully review all current medications during the online assessment to identify potential interactions and adjust treatment plans accordingly. Dehydration from vomiting or diarrhoea can impair kidney function, so maintaining adequate fluid intake is essential, particularly during the first month. At Cured Pharmacy, patients have direct access to our clinical team for any concerns about side effects or medication tolerability throughout their weight loss programme.

Who Can Use Saxenda Injection in the UK?

Treatment continuation with Saxenda injection should be reviewed after 12 weeks at the full 3mg maintenance dose. NICE recommends discontinuing liraglutide if patients have not achieved at least 5% weight loss from baseline by this point, as continued use is unlikely to produce clinically meaningful benefits [3]. Conversely, patients who respond well may continue treatment as long as they maintain weight loss and tolerate the medication, with periodic reassessment by prescribers to monitor for complications and evaluate ongoing appropriateness.

At Cured Pharmacy, every Saxenda injection prescription begins with a comprehensive online consultation reviewed by our UK-registered clinical team. This assessment evaluates your BMI, weight loss history, current medications, medical conditions, and treatment goals to determine suitability. Our superintendent pharmacist Tarun Kumar ensures all prescriptions meet MHRA standards and GPhC guidelines, providing the same rigorous clinical oversight you would receive from your NHS GP or specialist weight management service. Transparent pricing from £124.99 per pen means you know the exact cost before completing your assessment, with no hidden fees or surprise charges at checkout.

Eligibility Criteria and Contraindications

Saxenda injection is licensed in the UK for adults aged 18 and over with an initial BMI of 30 kg/m² or greater (obesity), or 27 kg/m² or greater (overweight) in the presence of at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidaemia, or obstructive sleep apnoea [3]. NICE guidance CG189 recommends considering pharmacological interventions only after dietary, exercise, and behavioural approaches have been insufficient to achieve meaningful weight loss, typically defined as less than 5% body weight reduction over 3-6 months of lifestyle modification alone.

Absolute contraindications to Saxenda injection include personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, pregnancy, breastfeeding, inflammatory bowel disease, and diabetic gastroparesis. The medication should be used with extreme caution in patients with severe renal or hepatic impairment, as these conditions can alter liraglutide pharmacokinetics and increase adverse event risk [2]. Our online clinical assessment systematically screens for these contraindications before any prescription is issued, ensuring patient safety remains paramount.

Saxenda Injection Results: What to Expect

Realistic expectations are crucial for long-term success with Saxenda injection therapy. In the pivotal SCALE trial, average weight loss at 56 weeks was 8% of initial body weight, meaning a 100kg patient might expect to lose approximately 8kg (just over 1 stone) [1]. However, individual results vary considerably—some patients lose 15% or more, while others achieve minimal response despite good adherence. Weight loss typically accelerates once the full 3mg dose is reached, with most reduction occurring in the first 6-8 months before plateauing.

The SCALE Maintenance trial demonstrated that Saxenda injection is particularly effective at preventing weight regain after initial diet-induced weight loss. Patients who had already lost 5% of body weight through lifestyle changes alone, then started liraglutide, maintained an additional 6.2% weight reduction compared to placebo over 56 weeks [2]. This suggests Saxenda may be most valuable as a maintenance tool to preserve hard-won weight loss, rather than solely as a first-line intervention. Combining the medication with ongoing dietary counselling, regular physical activity, and behavioural support optimises outcomes across all patient groups.

Monitoring progress involves more than just the number on the scale. Improvements in obesity-related comorbidities—such as reduced HbA1c in prediabetic patients, lower blood pressure, improved lipid profiles, and decreased waist circumference—often provide additional health benefits even when absolute weight loss is modest [3]. At Cured Pharmacy, we encourage patients to track these broader health markers alongside weight, celebrating non-scale victories that reflect meaningful metabolic improvements. Our clinical team remains available throughout your treatment to adjust expectations, troubleshoot challenges, and provide evidence-based guidance for maximising your Saxenda injection results.

Buying Saxenda Injection Online from Cured Pharmacy

Cured Pharmacy operates under the direct oversight of superintendent pharmacist Tarun Kumar (GPhC 2233073), ensuring every Saxenda injection prescription meets the highest professional standards. Our UK-registered clinical team has supported thousands of weight loss patients, combining deep pharmacological expertise with practical experience in obesity management. We understand the challenges of sustained weight loss and provide compassionate, non-judgemental care focused on helping you achieve your health goals safely and effectively.

Ongoing prescriptions are simplified through our online account system, where you can request repeat supplies, update medical information, and communicate with prescribers as your treatment progresses. We monitor for appropriate treatment duration, response to therapy, and any emerging safety concerns, discontinuing or adjusting treatment when clinically indicated. This comprehensive approach mirrors the care you would receive from specialist NHS weight management services, delivered with the convenience of online access and the affordability of our lowest-price guarantee. Start your Saxenda injection assessment today and take the first step toward sustainable, clinically-proven weight loss.

Our Prescription Process and Delivery

Purchasing Saxenda injection from Cured Pharmacy combines clinical rigour with convenient online access. Our process begins with a free online consultation taking under three minutes, covering your medical history, current medications, weight loss goals, and any contraindications. This assessment is reviewed by a UK-registered prescriber—either a GP or independent prescriber pharmacist—who determines whether Saxenda is safe and appropriate for you. If approved, your prescription is dispensed by our GPhC-registered pharmacy (9012511) and dispatched for next-day delivery in 100% discreet packaging.

We guarantee the lowest UK prices on genuine, MHRA-licensed Saxenda injection pens sourced directly from licensed wholesalers. At £124.99 per pen, our pricing is transparent and displayed before you begin the consultation, with no hidden fees added at checkout. New patients save an additional £124.99 using code Weightlossnew on their first order, making weight loss treatment more accessible without compromising on clinical safety or medication quality. All prescriptions include clear dosing instructions, injection technique guidance, and direct access to our pharmacist team for ongoing support.

Scientific References

1. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., ... & Wilding, J. P. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22.
2. Wadden, T. A., Hollander, P., Klein, S., Niswender, K., Woo, V., Hale, P. M., & Aronne, L. (2013). Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study. International Journal of Obesity, 37(11), 1443-1451.
3. Electronic Medicines Compendium. (2024). Saxenda 6 mg/ml solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC). Retrieved from https://www.medicines.org.uk/emc/product/2313/smpc

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.